These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 10327772)
41. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world]. Poli A; Menotti A G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121 [No Abstract] [Full Text] [Related]
42. [Are there differences in various statins?]. Otto C; Schwandt P Internist (Berl); 1998 Sep; 39(9):987-93. PubMed ID: 9788127 [No Abstract] [Full Text] [Related]
43. Cholesterol reduction and coronary prevention. Prabhakaran D Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704 [No Abstract] [Full Text] [Related]
44. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Hague W; Forder P; Simes J; Hunt D; Tonkin A; Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760 [TBL] [Abstract][Full Text] [Related]
45. [Cholesterol: blood levels or total risk as a guide to preventive treatment?]. Mathes P Z Kardiol; 2004; 93 Suppl 2():II16-20. PubMed ID: 15021991 [TBL] [Abstract][Full Text] [Related]
55. Lowering cholesterol in patients with coronary heart disease: are we ready yet? Barrett-Connor E Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875 [No Abstract] [Full Text] [Related]
56. The effects of changing statins on cholesterol levels. Mann S; Clare G N Z Med J; 1999 Jul; 112(1091):260. PubMed ID: 10448988 [No Abstract] [Full Text] [Related]
57. Prevention of coronary heart disease with pravastatin. Rogers S N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956 [No Abstract] [Full Text] [Related]
58. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate. Pharoah P BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009 [No Abstract] [Full Text] [Related]
59. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study. Muntoni S Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402 [No Abstract] [Full Text] [Related]